title: Impact of a dedicated infusion clinic for acute management of adults with sickle cell pain crisis.
abstract: Most adults with sickle cell disease (SCD) receive care for their acute painful episodes in an emergency department (ED) setting. The purpose of this article is to describe the impact of opening a dedicated treatment center for adults with SCD [Sickle Cell Infusion Clinic (SCIC)] on patient outcomes and on hospital discharges for SCD. Descriptive data including demographics, time to first dose of narcotic, and pain scores were collected on patients presenting to the SCIC and ED. Maryland hospital discharge data were obtained from the Maryland Health Services Cost Review Commission. Analyses were conducted using T tests, χ(2) tests, and simple generalized estimating equation regression models accounting for the clustered nature of observations, as appropriate. There were 3,874 visits to the SCIC by 361 unique patients; 85% of those visits resulted in the patient being sent home. During the same time period, there were 3,408 visits to the ED by 558 unique patients with SCD. The overall admission rate from the ED for these patients was 35.9% but decreased significantly over the time period with a rate of 20% in December 2011. There was a significant decrease in readmissions over time for the entire Baltimore Metro area with the likelihood of readmission decreasing by 7% over time. The SCIC model provides adults with SCD access to high quality care that decreases the need for hospital admission. Further research needs to be done to evaluate the cost effectiveness of this model.
authors: Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
authors: Sophie
authors: S
authors: Lanzkron
authors: C Patrick
authors: CP
authors: Carroll
authors: Peter
authors: P
authors: Hill
authors: Mandy
authors: M
authors: David
authors: Nicklaine
authors: N
authors: Paul
authors: Carlton
authors: C
authors: Haywood
mesh_terms: D000328:Adult; D000554:Ambulatory Care Facilities / Q000458:organization & administration*; D000755:Anemia, Sickle Cell / Q000150:complications / Q000191:economics / Q000503:physiopathology / Q000628:therapy*; D019468:Disease Management; D004636:Emergency Service, Hospital / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D008297:Male; D010146:Pain / Q000150:complications / Q000191:economics / Q000503:physiopathology*; D059408:Pain Management / Q000706:statistics & numerical data*; D010343:Patient Admission / Q000706:statistics & numerical data; D010351:Patient Discharge / Q000706:statistics & numerical data; D013997:Time Factors
references: Blood. 2000 Feb 15;95(4):1130-6
references: 10666181
references: Br J Haematol. 2004 Sep;126(6):878-80
references: 15352993
references: BMJ. 1988 Aug 13;297(6646):452-4
references: 3139140
references: N Engl J Med. 1994 Jun 9;330(23):1639-44
references: 7993409
references: J Adv Nurs. 1994 Apr;19(4):725-32
references: 8021394
references: Haematologica. 2007 Jun;92(6):854-5
references: 17550862
references: Pediatr Blood Cancer. 2008 Jul;51(1):82-5
references: 18383165
references: Pediatr Blood Cancer. 2008 Sep;51(3):398-401
references: 18300322
references: Pediatrics. 2009 Jan;123(1):407-12
references: 19117908
references: J Natl Med Assoc. 2009 Oct;101(10):1022-33
references: 19860302
references: Am J Prev Med. 2010 Apr;38(4 Suppl):S512-21
references: 20331952
references: Am J Hematol. 2010 Oct;85(10):797-9
references: 20730795
references: Am J Emerg Med. 2013 Apr;31(4):651-6
references: 23380119
references: J Health Care Poor Underserved. 2011 May;22(2):606-20
references: 21551937
references: Am J Emerg Med. 2011 Sep;29(7):752-6
references: 20825892
references: Am J Epidemiol. 2011 Oct 15;174(8):984-92
references: 21841157